切断後の慢性疼痛管理市場：タイプ別、治療タイプ別、エンドユーザー別-2025-2030年の世界予測

切断後の慢性疼痛管理市場は、2023年に56億5,000万米ドルと評価され、2024年には59億6,000万米ドルに達すると予測され、CAGR 5.66％で成長し、2030年には83億1,000万米ドルに達すると予測されています。

切断後の慢性疼痛管理には、四肢切断後の持続的な痛みを緩和するための戦略や治療法がまとめられています。この市場は、幻肢痛や残存肢痛に悩まされることの多い切断者の生活の質を高める上で極めて重要です。効果的な疼痛管理の必要性は、身体的・心理的に大きな課題に直面している切断者のアンメット・メディカル・ニーズによって強調されています。用途は、鎮痛剤や抗うつ剤などの医薬品から、神経ブロック、脊髄刺激、経皮的電気神経刺激などの高度な治療まで多岐にわたる。最終用途の範囲は主にヘルスケアプロバイダー、リハビリセンター、疼痛管理専門クリニックなどです。

市場成長は、糖尿病や末梢動脈疾患の罹患率の上昇による切断手術件数の増加の影響を受けています。疼痛管理療法の技術的進歩、個別化医療の重視、疼痛転帰予測モデルの開発における人工知能の統合が、潜在的なビジネスチャンスを生み出しています。企業はこのような機会を活用するため、共同パートナーシップや新規ドラッグデリバリーシステムの探求に注力すべきです。しかし、高額な治療費、不十分な償還政策、疼痛評価の複雑さなどの障壁が、市場の拡大を制限しています。

課題としては、誤診率の高さや、治療レジメンを複雑にする痛みの心理的側面などが挙げられます。事業成長のためには、オピオイドを使用しない疼痛管理ソリューションと、疼痛レベルを遠隔監視できるデジタル治療薬をイノベーションのターゲットとすべきです。バーチャルリアリティーや神経調節技術の導入は、有望な研究手段となります。市場は競争が激しく断片化されているため、小児疼痛管理や特定の患者層に合わせた介入など、ニッチな分野に戦略的に注力する必要があります。臨床試験と患者教育への継続的な投資により、治療の受容性を高め、市場浸透を促進することができます。この進化する情勢を乗り切るには、企業は患者中心のソリューションと強固な利害関係者の協力を優先しなければならないです。

市場力学：急速に進化する切断後の慢性疼痛管理市場における主要市場インサイトの解明

切断後の慢性疼痛管理市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 疼痛管理の選択肢に対する意識の高まりとヘルスケアインフラの改善
  • 薬理学的および非薬理学的疼痛管理療法への嗜好の高まり
  • 政府の支援政策とヘルスケア償還制度
• 市場抑制要因
  • 高額な治療費
• 市場機会
  • 神経調節技術の継続的な進歩
  • 個別化された治療計画を重視する患者中心のヘルスケアモデルの必要性
• 市場の課題
  • 専門医療従事者の不足と薬物副作用の問題

ポーターのファイブフォース：切断後の慢性疼痛管理市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：切断後の慢性疼痛管理市場における外部からの影響の把握

外部マクロ環境要因は、切断後の慢性疼痛管理市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析切断後の慢性疼痛管理市場における競合情勢の把握

切断後の慢性疼痛管理市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス切断後の慢性疼痛管理市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、切断後の慢性疼痛管理市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨切断後の慢性疼痛管理市場における成功への道筋を描く

切断後の慢性疼痛管理市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 疼痛管理方法とヘルスケアインフラの改善に対する意識の高まり
    • 薬物療法および非薬物療法による疼痛管理療法への関心が高まっている
    • 政府の支援政策とヘルスケアの償還
  • 抑制要因
    • 治療オプションのコストが高い
  • 機会
    • 神経調節技術の継続的な進歩
    • 個別化された治療計画を重視した患者中心のヘルスケアモデルの必要性
  • 課題
    • 専門医療従事者の不足と薬の副作用に関連する問題
• 市場セグメンテーション分析
  • タイプ：幻肢疼痛管理の需要が高まり、痛みを和らげて生活の質を向上
  • 最終用途：病院における切断後の慢性疼痛管理の需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 切断後の慢性疼痛管理市場：タイプ別

• 神経腫の痛み
• 幻肢痛
• 切断面の痛み

第7章 切断後の慢性疼痛管理市場治療の種類別

• 薬物治療
• 神経調節技術
• 外科的介入
• 治療
  • ミラーセラピー
  • 理学療法
  • 心理療法

第8章 切断後の慢性疼痛管理市場：最終用途別

• ホームケア
• 病院
• ペインクリニック
• リハビリテーションセンター

第9章 南北アメリカの切断後の慢性疼痛管理市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の切断後の慢性疼痛管理市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの切断後の慢性疼痛管理市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • トリニティ・キャピタル、切断患者の疼痛管理強化のためニューロス・メディカルに投資
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Advanced Arm Dynamics, Inc.
• Aspen Pharmacare Holdings Limited
• AstraZeneca PLC
• ATI Physical Therapy
• B. Braun Melsungen AG
• Einstein Healthcare Network
• GlaxoSmithKline PLC
• Memorial Healthcare System
• Novartis AG
• Pfizer Inc.
• Physiopedia
• Propel Physiotherapy
• Select Medical Corporation
• Smart Solutions Rehab Group
• Teva Pharmaceutical Industries Ltd.
• The Rehabilitation Hospital of Montana

LIST OF FIGURES

• FIGURE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET RESEARCH PROCESS
• FIGURE 2. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET DYNAMICS
• TABLE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMA PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STUMP PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMODULATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MIRROR THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 63. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 67. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 136. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 152. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 156. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 193. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Chronic Post-Amputation Pain Management Market was valued at USD 5.65 billion in 2023, expected to reach USD 5.96 billion in 2024, and is projected to grow at a CAGR of 5.66%, to USD 8.31 billion by 2030.

Chronic Post-Amputation Pain Management encapsulates the strategies and treatments designed to alleviate persistent pain experienced by individuals following limb amputation. This market is critical in enhancing the quality of life for amputees, who often suffer from phantom limb pain or residual limb pain. The necessity of effective pain management is underscored by the unmet medical needs of amputees facing significant physical and psychological challenges. Applications range from pharmaceutical medications, such as analgesics and antidepressants, to advanced therapies like nerve blocks, spinal cord stimulation, and transcutaneous electrical nerve stimulation. The end-use scope primarily includes healthcare providers, rehabilitation centers, and specialized pain management clinics.

The market growth is being influenced by an increasing number of amputation surgeries due to rising incidences of diabetes and peripheral arterial disease. Technological advancements in pain management therapies, a greater emphasis on personalized medicine, and the integration of artificial intelligence in developing predictive models for pain outcomes are creating potential opportunities. Companies should focus on collaborative partnerships and exploring novel drug-delivery systems to tap into these opportunities. However, barriers such as high treatment costs, inadequate reimbursement policies, and the complexity of pain assessment limit market expansion.

Challenging factors include the high rate of misdiagnosis and the psychological aspect of pain that complicates treatment regimens. For business growth, innovation should target non-opioid pain management solutions and digital therapeutics that can monitor pain levels remotely. Incorporation of virtual reality and neuromodulation technologies offers promising research avenues. The market is competitive and fragmented, requiring a strategic focus on niche segments like pediatric pain management and tailored interventions for specific patient demographics. Continued investment in clinical trials and patient education can enhance treatment acceptance and drive market penetration. To navigate this evolving landscape, companies must prioritize patient-centric solutions and robust stakeholder collaboration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising awareness of pain management options and better healthcare infrastructure
  • Increasing preference for pharmacological and non-pharmacological pain management therapies
  • Supportive government policies and healthcare reimbursement
• Market Restraints
  • High cost of treatment options
• Market Opportunities
  • Ongoing advancements in neuromodulation technologies
  • Need for patient-centric healthcare models emphasizing personalized treatment plans
• Market Challenges
  • Limited availability of specialized medical professionals and issues associated with medication side effects

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Post-Amputation Pain Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Post-Amputation Pain Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Post-Amputation Pain Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Post-Amputation Pain Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Post-Amputation Pain Management Market

A detailed market share analysis in the Chronic Post-Amputation Pain Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Post-Amputation Pain Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Post-Amputation Pain Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Post-Amputation Pain Management Market

A strategic analysis of the Chronic Post-Amputation Pain Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.

Market Segmentation & Coverage

This research report categorizes the Chronic Post-Amputation Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Neuroma Pain, Phantom Limb Pain, and Stump Pain.
• Based on Treatment Type, market is studied across Medication, Neuromodulation Techniques, Surgical Interventions, and Therapy. The Therapy is further studied across Mirror Therapy, Physical Therapy, and Psychological Therapy.
• Based on End-Use, market is studied across Home Care, Hospitals, Pain Clinics, and Rehabilitation Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness of pain management options and better healthcare infrastructure
    • 5.1.1.2. Increasing preference for pharmacological and non-pharmacological pain management therapies
    • 5.1.1.3. Supportive government policies and healthcare reimbursement
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment options
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in neuromodulation technologies
    • 5.1.3.2. Need for patient-centric healthcare models emphasizing personalized treatment plans
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of specialized medical professionals and issues associated with medication side effects
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
  • 5.2.2. End-Use: Growing need for chronic post-amputation pain management in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Chronic Post-Amputation Pain Management Market, by Type

• 6.1. Introduction
• 6.2. Neuroma Pain
• 6.3. Phantom Limb Pain
• 6.4. Stump Pain

7. Chronic Post-Amputation Pain Management Market, by Treatment Type

• 7.1. Introduction
• 7.2. Medication
• 7.3. Neuromodulation Techniques
• 7.4. Surgical Interventions
• 7.5. Therapy
  • 7.5.1. Mirror Therapy
  • 7.5.2. Physical Therapy
  • 7.5.3. Psychological Therapy

8. Chronic Post-Amputation Pain Management Market, by End-Use

• 8.1. Introduction
• 8.2. Home Care
• 8.3. Hospitals
• 8.4. Pain Clinics
• 8.5. Rehabilitation Centers

9. Americas Chronic Post-Amputation Pain Management Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Chronic Post-Amputation Pain Management Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Chronic Post-Amputation Pain Management Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Advanced Arm Dynamics, Inc.
• 3. Aspen Pharmacare Holdings Limited
• 4. AstraZeneca PLC
• 5. ATI Physical Therapy
• 6. B. Braun Melsungen AG
• 7. Einstein Healthcare Network
• 8. GlaxoSmithKline PLC
• 9. Memorial Healthcare System
• 10. Novartis AG
• 11. Pfizer Inc.
• 12. Physiopedia
• 13. Propel Physiotherapy
• 14. Select Medical Corporation
• 15. Smart Solutions Rehab Group
• 16. Teva Pharmaceutical Industries Ltd.
• 17. The Rehabilitation Hospital of Montana